Ligand Partner Rib-X Initiates Phase 3 Trial of Captisol-Enabled™ Delafloxacin IV

Published May 18, 2013

Ligand Partner Rib-X Initiates Phase 3 Trial of Captisol-enabled™ Delafloxacin IV

Filed under: drug treatment programs in san diego

SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that its partner Rib-X Pharmaceuticals, Inc. has initiated a Phase 3 clinical trial of a Captisol-enabled™ intravenous (IV) formulation of delafloxacin for …
Read more on EON: Enhanced Online News (press release)

Cholesterol Drugs May Boost Kidney Cancer Survival

Filed under: drug treatment programs in san diego

The new research, presented Tuesday at the annual meeting of the American Urological Association in San Diego, suggests that the drugs might fight kidney cancer. "Given that one in four Americans over 45 years of age take a statin and renal cell …
Read more on WebMD

Partnership Formed to Explore Personalized Medicine Approach for …

Filed under: drug treatment programs in san diego

SAN DIEGO, May 10, 2013 /PRNewswire-USNewswire/ — The ALS Emergency Treatment Fund (ALS-ETF) and Denovo Biomarkers (Denovo) have announced a partnership to explore using Denovo's technology to identify potential responder groups for drugs being …
Read more on PR Newswire (press release)